Clinicopathological Significance of CD44 and CD117 Expression/Co-Expression in Invasive Ductal Breast Cancer.

Djordjevic M, Karanikolic A, Velickovic L

Open source

DOI
10.3390/diagnostics16203401
Published
2026 Oct 19
Container
Diagnostics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics16203401,
  title = {Clinicopathological Significance of CD44 and CD117 Expression/Co-Expression in Invasive Ductal Breast Cancer.},
  author = {Djordjevic M and Karanikolic A and Velickovic L},
  year = {2026},
  journal = {Diagnostics (Basel, Switzerland)},
  doi = {10.3390/diagnostics16203401},
  url = {https://doi.org/10.3390/diagnostics16203401}
}

RIS

TY  - JOUR
TI  - Clinicopathological Significance of CD44 and CD117 Expression/Co-Expression in Invasive Ductal Breast Cancer.
AU  - Djordjevic M
AU  - Karanikolic A
AU  - Velickovic L
PY  - 2026
JO  - Diagnostics (Basel, Switzerland)
DO  - 10.3390/diagnostics16203401
UR  - https://doi.org/10.3390/diagnostics16203401
ER  - 

APA

M, D., A, K., & L, V. (2026). Clinicopathological Significance of CD44 and CD117 Expression/Co-Expression in Invasive Ductal Breast Cancer.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16203401

Source records